Xuening Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xuening Wang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Byu-Ri Sim
State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, MOE-LSB & MOE-LSC, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
1 shared publication- Chang Wang
Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, USA
1 shared publication - Deping Wang
Key Laboratory of Regenerative Biology and Institute of Chemical Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
1 shared publication Diying Zhu
Department of Pharmacology, Shanxi Medical University, Taiyuan 030001, China
1 shared publication- Haixiong Wang
Shanxi Key Laboratory of Heart Failure Precision Medicine, Cardiovascular Hospital Affiliated to Shanxi Medical University, 030024 Taiyuan, Shanxi, China
1 shared publication He-Wei Jiang
Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China
1 shared publication
Latest Publications
- 1 May 2025
- Published by Wiley in International Journal of Tourism Research
- Vol. 27 (3)
Exploring Features, Customer Emotions, and Evaluations of Airbnb Online Experiences: A Framework for Virtual Tourism Experiences
This study proposes a conceptual framework grounded in the Stimulus‐Organism‐Response theory (S‐O‐R) to investigate the relationship between virtual tourism experience features, customer emotions, and their evaluations. Through a hybrid approach combining automated aspect extraction and manual annotation, five key features of online experiences (OEs) are identified: host attributes, activity design and experiential value, technology and technical tools, value for money, and personalization. Leveraging deep learning‐based emotion analysis, the research maps customer emotional states along a spectrum from positive (e.g., admiration, gratitude, approval, optimism) to neutral or negative (e.g., disappointment, disapproval). Empirical findings reveal that OE features systematically trigger emotional responses, as validated through sentiment classification techniques. Moreover, ridge regression analysis confirms that these emotional states are strong predictors of OE ratings, explaining a significant proportion of variance in customer evaluations. This work advances the theoretical understanding of virtual tourism experience design and offers actionable strategies for platform optimization.
- 1 May 2025
- Published by Wiley in International Journal of Tourism Research
- Vol. 27 (3)
Exploring Features, Customer Emotions, and Evaluations of Airbnb Online Experiences: A Framework for Virtual Tourism Experiences
This study proposes a conceptual framework grounded in the Stimulus‐Organism‐Response theory (S‐O‐R) to investigate the relationship between virtual tourism experience features, customer emotions, and their evaluations. Through a hybrid approach combining automated aspect extraction and manual annotation, five key features of online experiences (OEs) are identified: host attributes, activity design and experiential value, technology and technical tools, value for money, and personalization. Leveraging deep learning‐based emotion analysis, the research maps customer emotional states along a spectrum from positive (e.g., admiration, gratitude, approval, optimism) to neutral or negative (e.g., disappointment, disapproval). Empirical findings reveal that OE features systematically trigger emotional responses, as validated through sentiment classification techniques. Moreover, ridge regression analysis confirms that these emotional states are strong predictors of OE ratings, explaining a significant proportion of variance in customer evaluations. This work advances the theoretical understanding of virtual tourism experience design and offers actionable strategies for platform optimization.
- 21 December 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 42 (5) , 816-827
Nerve growth factor (Ngf) gene-driven semaphorin 3a (Sema3a) expression exacerbates thoracic aortic aneurysm dissection in mice
Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening disease and currently there is no pharmacological therapy. Sympathetic nerve overactivity plays an important role in the development of TAAD. Sympathetic innervation is mainly controlled by nerve growth factor (NGF, a key neural chemoattractant) and semaphoring 3A (Sema3A, a key neural chemorepellent), while the roles of these two factors in aortic sympathetic innervation and especially TAAD are unknown. We hypothesized that genetically manipulating the NGF/Sema3A ratio by the Ngf-driven Sema3a expression approach may reduce aortic sympathetic nerve innervation and mitigate TAAD progression. A mouse strain of Ngf gene-driven Sema3a expression (namely Ngf Sema3a/Sema3a mouse) was established by inserting the 2A-Sema3A expression frame to the Ngf terminating codon using CRISPR/Cas9 technology. TAAD was induced by β-aminopropionitrile monofumarate (BAPN) both in Ngf Sema3a/Sema3a mice and wild type (WT) littermates. Contrary to our expectation, the BAPN-induced TAAD was severer in Ngf Sema3a/Sema3a mice than in wild-type (WT) mice. In addition, Ngf Sema3a/Sema3a mice showed higher aortic sympathetic innervation, inflammation and extracellular matrix degradation than the WT mice after BAPN treatment. The aortic vascular smooth muscle cells isolated from Ngf Sema3a/Sema3a mice and pretreated with BAPN in vivo for two weeks showed stronger capabilities of proliferation and migration than that from the WT mice. We conclude that the strategy of Ngf-driven Sema3a expression cannot suppress but worsens the BAPN-induced TAAD. By investigating the aortic phenotype of Ngf Sema3a/Sema3a mouse strain, we unexpectedly find a path to exacerbate BAPN-induced TAAD which might be useful in future TAAD studies.
- 21 December 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 42 (5) , 816-827
Nerve growth factor (Ngf) gene-driven semaphorin 3a (Sema3a) expression exacerbates thoracic aortic aneurysm dissection in mice
Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening disease and currently there is no pharmacological therapy. Sympathetic nerve overactivity plays an important role in the development of TAAD. Sympathetic innervation is mainly controlled by nerve growth factor (NGF, a key neural chemoattractant) and semaphoring 3A (Sema3A, a key neural chemorepellent), while the roles of these two factors in aortic sympathetic innervation and especially TAAD are unknown. We hypothesized that genetically manipulating the NGF/Sema3A ratio by the Ngf-driven Sema3a expression approach may reduce aortic sympathetic nerve innervation and mitigate TAAD progression. A mouse strain of Ngf gene-driven Sema3a expression (namely Ngf Sema3a/Sema3a mouse) was established by inserting the 2A-Sema3A expression frame to the Ngf terminating codon using CRISPR/Cas9 technology. TAAD was induced by β-aminopropionitrile monofumarate (BAPN) both in Ngf Sema3a/Sema3a mice and wild type (WT) littermates. Contrary to our expectation, the BAPN-induced TAAD was severer in Ngf Sema3a/Sema3a mice than in wild-type (WT) mice. In addition, Ngf Sema3a/Sema3a mice showed higher aortic sympathetic innervation, inflammation and extracellular matrix degradation than the WT mice after BAPN treatment. The aortic vascular smooth muscle cells isolated from Ngf Sema3a/Sema3a mice and pretreated with BAPN in vivo for two weeks showed stronger capabilities of proliferation and migration than that from the WT mice. We conclude that the strategy of Ngf-driven Sema3a expression cannot suppress but worsens the BAPN-induced TAAD. By investigating the aortic phenotype of Ngf Sema3a/Sema3a mouse strain, we unexpectedly find a path to exacerbate BAPN-induced TAAD which might be useful in future TAAD studies.
- Open Access
- 1 October 2022
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 54 (10) , 1453-1463
Identification of sitagliptin binding proteins by affinity purification mass spectrometry
Type 2 diabetes mellitus (T2DM) is recognized as a serious public health concern with increasing incidence. The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin has been used for the treatment of T2DM worldwide. Although sitagliptin has excellent therapeutic outcome, adverse effects are observed. In addition, previous studies have suggested that sitagliptin may have pleiotropic effects other than treating T2DM. These pieces of evidence point to the importance of further investigation of the molecular mechanisms of sitagliptin, starting from the identification of sitagliptin-binding proteins. In this study, by combining affinity purification mass spectrometry (AP-MS) and stable isotope labeling by amino acids in cell culture (SILAC), we discover seven high-confidence targets that can interact with sitagliptin. Surface plasmon resonance (SPR) assay confirms the binding of sitagliptin to three proteins, i. e., LYPLAL1, TCP1, and CCAR2, with binding affinities (K D) ranging from 50.1 μM to 1490 μM. Molecular docking followed by molecular dynamic (MD) simulation reveals hydrogen binding between sitagliptin and the catalytic triad of LYPLAL1, and also between sitagliptin and the P-loop of ATP-binding pocket of TCP1. Molecular mechanics Poisson-Boltzmann Surface Area (MMPBSA) analysis indicates that sitagliptin can stably bind to LYPLAL1 and TCP1 in active sites, which may have an impact on the functions of these proteins. SPR analysis validates the binding affinity of sitagliptin to TCP1 mutant D88A is ~10 times lower than that to the wild-type TCP1. Our findings provide insights into the sitagliptin-targets interplay and demonstrate the potential of sitagliptin in regulating gluconeogenesis and in anti-tumor drug development.
- 1 October 2022
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 54 (10) , 1453-1463
Open AccessIdentification of sitagliptin binding proteins by affinity purification mass spectrometry
Type 2 diabetes mellitus (T2DM) is recognized as a serious public health concern with increasing incidence. The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin has been used for the treatment of T2DM worldwide. Although sitagliptin has excellent therapeutic outcome, adverse effects are observed. In addition, previous studies have suggested that sitagliptin may have pleiotropic effects other than treating T2DM. These pieces of evidence point to the importance of further investigation of the molecular mechanisms of sitagliptin, starting from the identification of sitagliptin-binding proteins. In this study, by combining affinity purification mass spectrometry (AP-MS) and stable isotope labeling by amino acids in cell culture (SILAC), we discover seven high-confidence targets that can interact with sitagliptin. Surface plasmon resonance (SPR) assay confirms the binding of sitagliptin to three proteins, i. e., LYPLAL1, TCP1, and CCAR2, with binding affinities (K D) ranging from 50.1 μM to 1490 μM. Molecular docking followed by molecular dynamic (MD) simulation reveals hydrogen binding between sitagliptin and the catalytic triad of LYPLAL1, and also between sitagliptin and the P-loop of ATP-binding pocket of TCP1. Molecular mechanics Poisson-Boltzmann Surface Area (MMPBSA) analysis indicates that sitagliptin can stably bind to LYPLAL1 and TCP1 in active sites, which may have an impact on the functions of these proteins. SPR analysis validates the binding affinity of sitagliptin to TCP1 mutant D88A is ~10 times lower than that to the wild-type TCP1. Our findings provide insights into the sitagliptin-targets interplay and demonstrate the potential of sitagliptin in regulating gluconeogenesis and in anti-tumor drug development.
- Open Access
- 24 May 2022
- Published by IMR Press in The Heart Surgery Forum
- Vol. 25 (3) , E391-E394
Total Arch Replacement Combined with Stented Elephant Trunk Implantation for Acute Type A Aortic Dissection in an Octogenarian Patient
Background: The indications and outcome of surgery for Acute type A aortic dissection (ATAAD) in elderly patients are still debated, especially when they were above 80 years old. Case presentation: This report describes the case of an octogenarian patient with ATAAD who underwent total arch replacement (TAR) combined with stented elephant trunk (SET) implantation. Conclusion: Emergent surgery should be performed on the ATAAD octogenarians without serious preoperative complications. Acceptable outcomes could be received by total arch replacement combined with SET implantation.
- 24 May 2022
- Published by IMR Press in The Heart Surgery Forum
- Vol. 25 (3) , E391-E394
Open AccessTotal Arch Replacement Combined with Stented Elephant Trunk Implantation for Acute Type A Aortic Dissection in an Octogenarian Patient
Background: The indications and outcome of surgery for Acute type A aortic dissection (ATAAD) in elderly patients are still debated, especially when they were above 80 years old. Case presentation: This report describes the case of an octogenarian patient with ATAAD who underwent total arch replacement (TAR) combined with stented elephant trunk (SET) implantation. Conclusion: Emergent surgery should be performed on the ATAAD octogenarians without serious preoperative complications. Acceptable outcomes could be received by total arch replacement combined with SET implantation.
- 1 August 2018
- Published by Elsevier in Life Sciences
- Vol. 207, 442-450
Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition
- 1 August 2018
- Published by Elsevier in Life Sciences
- Vol. 207, 442-450
Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition